blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3152234

EP3152234 - ANTIBODY WHICH IS DIRECTED AGAINST GALECTIN-9 AND IS AN INHIBITOR OF THE SUPPRESSOR ACTIVITY OF REGULATORY T LYMPHOCYTES [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  24.05.2024
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  05.06.2020
FormerGrant of patent is intended
Status updated on  27.04.2020
FormerExamination is in progress
Status updated on  26.01.2018
FormerRequest for examination was made
Status updated on  10.03.2017
FormerThe international publication has been made
Status updated on  09.12.2016
Most recent event   Tooltip24.05.2024Patent maintained (B2 publication)published on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Université de Lille
42, rue Paul Duez
59800 Lille / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Institut Gustave Roussy
39, rue Camille Desmoulins
94800 Villejuif / FR
For all designated states
Cellvax
102 avenue Gaston Roussel
93230 Romainville / FR
For all designated states
Université Paris-Saclay
Espace Technologique de Saint-Aubin
Immeuble Discovery
Route de l'Orme des Merisiers - RD 128
91190 Saint-Aubin / FR
[2020/24]
Former [2017/20]For all designated states
Université des Sciences et Technologies de Lille 1
Cité Scientifique
59650 Villeneuve-d'Ascq / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Institut Gustave Roussy
39, rue Camille Desmoulins
94800 Villejuif / FR
For all designated states
Cellvax
102 avenue Gaston Roussel
93230 Romainville / FR
For all designated states
Université du Droit et de la Santé de Lille 2
42 rue Paul Duez
59800 Lille / FR
For all designated states
Universite Paris-Sud
15, rue Georges Clémenceau
91400 Orsay / FR
Former [2017/15]For all designated states
Université des Sciences et Technologies de Lille 1
Cité Scientifique
59650 Villeneuve-d'Ascq / FR
For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Institut Gustave Roussy
39, rue Camille Desmoulins
94800 Villejuif / FR
For all designated states
Cellvax
102 Avenue Gaston Roussel
93230 Romainville / FR
For all designated states
Université du Droit et de la Santé de Lille 2
42 rue Paul Duez
59800 Lille / FR
For all designated states
Universite Paris-Sud
15, rue Georges Clémenceau
91400 Orsay / FR
Inventor(s)01 / DELHEM, Nadira
10 Rue Adolphe Torgue
F-59700 Marcq en Baroeul / FR
02 / BUSSON, Pierre
8 Rue du Moulin
F-92160 Antony / FR
03 / MORALES, Olivier
10/12 Rue du Priez
F-59000 Lille / FR
04 / BARJON, Clément
36 Boulevard Maxime Gorki
F-94800 Villejuif / FR
05 / MRIZAK, Dhafer
101 Rue Colbert
F-59000 Lille / FR
06 / LHUILLIER, Claire
49 Rue du Général Leclerc
F-94270 Le Kremlin-Bicêtre / FR
07 / MUSTAPHA, Rami
275 Rue des Postes (3ème étage)
F-59000 Lille / FR
 [2017/15]
Representative(s)Plasseraud IP
104 Rue de Richelieu
CS92104
75080 Paris Cedex 02 / FR
[N/P]
Former [2020/28]Plasseraud IP
31, rue des Poissonceaux
CS 40009
59044 Lille Cedex / FR
Former [2017/15]Cabinet Plasseraud
31, rue des Poissonceaux
CS 40009
59044 Lille Cedex / FR
Application number, filing date15732846.905.06.2015
[2017/15]
WO2015FR51498
Priority number, dateFR2014005517706.06.2014         Original published format: FR 1455177
[2017/15]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2015185875
Date:10.12.2015
Language:FR
[2015/49]
Type: A2 Application without search report 
No.:EP3152234
Date:12.04.2017
Language:FR
The application published by WIPO in one of the EPO official languages on 10.12.2015 takes the place of the publication of the European patent application.
[2017/15]
Type: B1 Patent specification 
No.:EP3152234
Date:08.07.2020
Language:FR
[2020/28]
Type: B2 New European patent specification 
No.:EP3152234
Date:26.06.2024
Language:FR
[2024/26]
Search report(s)International search report - published on:EP18.02.2016
ClassificationIPC:A61P35/00, A61P35/02, A61P43/00, C07K16/28, C07K16/30, A61K39/00
[2023/47]
CPC:
C07K16/2851 (EP,US); C07K16/18 (CN,US); A61K39/3955 (US);
A61K45/06 (US); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP); C07K16/30 (US); C07K16/3084 (EP);
C07K16/3092 (CN,US); A61K2039/505 (EP,US); C07K2317/34 (EP,CN,US);
C07K2317/56 (EP,CN,US); C07K2317/565 (EP,CN,US); C07K2317/76 (EP,CN,US) (-)
Former IPC [2017/15]C07K16/18, C07K16/30
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/15]
TitleGerman:GEGEN GALECTIN-9 GERICHTETER ANTIKÖRPER ALS HEMMER DER SUPPRESSORWIRKUNG VON REGULATORISCHEN T-LYMPHOZYTEN[2017/15]
English:ANTIBODY WHICH IS DIRECTED AGAINST GALECTIN-9 AND IS AN INHIBITOR OF THE SUPPRESSOR ACTIVITY OF REGULATORY T LYMPHOCYTES[2017/15]
French:ANTICORPS DIRIGÉ CONTRE LA GALECTINE 9 ET INHIBITEUR DE L'ACTIVITÉ SUPPRESSIVE DES LYMPHOCYTES T RÉGULATEURS[2017/15]
Entry into regional phase08.12.2016National basic fee paid 
08.12.2016Designation fee(s) paid 
08.12.2016Examination fee paid 
Examination procedure08.12.2016Examination requested  [2017/15]
08.12.2016Date on which the examining division has become responsible
21.07.2017Amendment by applicant (claims and/or description)
29.01.2018Despatch of a communication from the examining division (Time limit: M04)
05.06.2018Reply to a communication from the examining division
07.09.2018Despatch of a communication from the examining division (Time limit: M04)
08.11.2018Reply to a communication from the examining division
07.12.2018Observations by third parties
15.01.2019Observations by third parties
29.03.2019Despatch of a communication from the examining division (Time limit: M08)
09.12.2019Reply to a communication from the examining division
12.02.2020Observations by third parties
17.02.2020Observations by third parties
28.04.2020Communication of intention to grant the patent
30.04.2020Fee for grant paid
30.04.2020Fee for publishing/printing paid
30.04.2020Receipt of the translation of the claim(s)
07.05.2020Observations by third parties
Divisional application(s)EP20184087.3  / EP3747908
Opposition(s)Opponent(s)01  08.04.2021  06.07.2023  WITHDRAWN
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
Opponent's representative
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
 [2023/33]
Former [2021/20]
Opponent(s)01  08.04.2021   
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
Opponent's representative
Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
23.04.2021Invitation to proprietor to file observations on the notice of opposition
25.10.2021Reply of patent proprietor to notice(s) of opposition
11.07.2023Cancellation of oral proceeding that was planned for 12.09.2023
11.08.2023Despatch of a communication from the opposition division (Time limit: M02)
12.09.2023Date of oral proceedings
11.10.2023Reply to a communication from the opposition division
02.11.2023Despatch of interlocutory decision in opposition
12.11.2023Legal effect of interlocutory decision in opposition
12.02.2024Despatch of communication that the patent will be maintained as amended
Fees paidRenewal fee
30.05.2017Renewal fee patent year 03
28.05.2018Renewal fee patent year 04
27.05.2019Renewal fee patent year 05
22.05.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL08.07.2020
CY08.07.2020
CZ08.07.2020
EE08.07.2020
LV08.07.2020
MC08.07.2020
MK08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
[2024/22]
Former [2023/30]AL08.07.2020
CY08.07.2020
CZ08.07.2020
EE08.07.2020
LV08.07.2020
MC08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
Former [2022/08]AL08.07.2020
CZ08.07.2020
EE08.07.2020
LV08.07.2020
MC08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
Former [2021/28]AL08.07.2020
CZ08.07.2020
EE08.07.2020
LV08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SK08.07.2020
SM08.07.2020
BG08.10.2020
Former [2021/25]AL08.07.2020
CZ08.07.2020
EE08.07.2020
LV08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SM08.07.2020
BG08.10.2020
Former [2021/22]CZ08.07.2020
EE08.07.2020
LV08.07.2020
PL08.07.2020
RO08.07.2020
RS08.07.2020
SM08.07.2020
BG08.10.2020
Former [2021/10]LV08.07.2020
PL08.07.2020
RS08.07.2020
BG08.10.2020
Cited inInternational search[XI]WO2010084999  (PROTEGENE INC [JP], et al);
 [A]WO2012177788  (JOLLA INST ALLERGY IMMUNOLOG [US], et al);
by applicantEP0173494
 WO9514785
 WO9622378
 WO9845322
 US5882877
 EP1586325
otherWO2010084999
 US8329660
OppositionWO2010084999
 US8329660
 WO2014144600
 WO2016073299
 WO2021139682
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.